I have been asked to forward this to the list.
Please reply to the details given and not to me.
>Organisers: The NSW Branch of the Statistical Society of Australia Inc,
>Covance Pty Ltd and ARCS*
>Title: Meta-analysis for Drug Development
>Location: Training Room 248, Executive Hotel and Conference Centre
>Macquarie Graduate School of Management, Talavera Road, North Ryde, Sydney NSW
>Presenter: Stephen Senn, University of Glasgow
>
> From Karl Pearson's analysis in 1904 in the BMJ of inoculation for
>enteric fever to Juni et al's analysis in 2004 in the Lancet of risks of
>cardiovascular events in taking rofecoxib, meta-analysis has now
>achieved a century of use and controversy. In this course Stephen Senn
>will cover the practicalities of carrying out meta-analysis
>concentrating not only on different models for analysis but also on
>contentious matters such as when and when not to pool. Some parallels to
>the analysis of multi-centre trials will be made and attention will also
>be drawn to some differences in practice between 'public' organisations
>such as the Cochrane Collaboration and commercial organisation such as
>pharmaceutical sponsors. Common pitfalls will be covered. Case studies
>will include the controversy over breast cancer screening and that of
>rofecoxib and heart disease.
>
>
>To register see the further details at
>http://web.maths.unsw.edu.au/~inge/ssai_nsw/docs/Meta-analysis%20Flyer.pdf
>
>Deadline for early registration 31 January SSAI or ARCS Member AUS$710 Non
>member AUS$890
>Deadline for registration 15 March SSAI or ARCS Member AUS$ 820 Non
>member AUS$1000
>
>
>*Australian Regulatory & Clinical Scientists Australia
|